EWTX Dividend History & Analysis | N/A Yield

EWTX has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

As of November 2025, Edgewise Therapeutics (EWTX) does not pay a dividend.

Top Dividend Payers in Biotechnology

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap (USD) Dividend Yield TTM Yield on Cost (purchase 5y ago)
JBIO 280 M 24.5% 0.31%
ABBV 403,129 M 3.01% 9.03%
GILD 150,063 M 2.62% 6.53%
AMGN 157,202 M 3.15% 4.99%
HLN 41,279 M 1.90% 2.46%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap (USD) Growth Rate (CAGR) Payout Consistency
GRFS 8,004 M 127% 60.7%
HLN 41,279 M 51.0% 100%
AMGN 157,202 M 8.90% 100%
ABBV 403,129 M 7.06% 100%
GILD 150,063 M 3.16% 100%

Similar Stocks with Attractive Dividends - Compare EWTX Dividends with its Peer-Group

ABBV
AbbVie
3.01% Yield
AMGN
Amgen
3.15% Yield
GILD
Gilead Sciences
2.62% Yield
HLN
Haleon
1.90% Yield

EWTX Dividend History: as of November 2025

No dividends paid yet.

EWTX Dividend FAQ

Edgewise Therapeutics Inc (NASDAQ:EWTX) is a biotechnology company listed on the NASDAQ stock exchange. As a player in the biotechnology sub-industry, the companys primary focus is on developing innovative treatments, likely for rare or genetic disorders.

What is the Dividend Yield of EWTX?

As of November 2025, EWTX`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 18.28.

Does EWTX pay a dividend?

As of November 2025 EWTX does not pay a dividend.

How often does EWTX pay dividends?

Over the last 12 months, EWTX has issued dividend payments.

Will EWTX pay dividends in 2025?

The next Ex-Dividend date for Edgewise Therapeutics (EWTX) is currently unknown.

What is the next Ex-Dividend Date for EWTX?

The next Ex-Dividend date for Edgewise Therapeutics (EWTX) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of EWTX?

EWTX's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of EWTX?

EWTX's 5-Year Yield on Cost is -%. If you bought EWTX's shares at 30.00 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of EWTX?

EWTX Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.

Does EWTX have a good Dividend Yield?

EWTX`s % Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of EWTX?

The Dividend Payout Ratio of EWTX is unknown.

What is the Dividend Rating of EWTX?

EWTX`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

EWTX Outstanding Shares Analysis

What is the Trend in EWTX`s Outstanding Shares (CAGR)?

Edgewise Therapeutics`s outstanding shares have increased by approximately 27.28% annually over the past 3 years (Correlation: 100.0%), negatively influencing the share price.

Has Edgewise Therapeutics ever had a Stock Split?

No Stock Splits found.
Year Number of Shares Annual Growth Rate
2020 20,338,100
2021 49,264,900 +142.23%
2022 63,231,600 +28.35%
2023 64,774,800 +2.44%
2024 92,414,600 +42.67%
2025 104,940,500 +13.55%

Key Metric Definitions

  • Dividend Yield: Annual dividend per share divided by current share price.
  • Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
  • Payout Ratio: Percentage of earnings paid as dividends (TTM).
  • Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
  • Payout Frequency: Number of dividends paid in the last 12m (TTM).
  • Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
  • Total Return: Price appreciation plus dividends over specified period.
  • Market Cap: Figures are in millions of the corresponding currency.

Last update: 2025-10-17 04:39